An OCD Prevention Programme for at Risk Adults

Not Applicable

Recruiting

• Conditions: Obsessive-Compulsive Disorder
• Interventions: Behavioral: Prevention

• Registration Number: NCT06262464
• Lead Sponsor: Babes-Bolyai University

Brief Summary

The main purpose of this randomised clinical trial is to test the efficacy of a prevention program for adult who are at risk of developing OCD, thus constituting a form of tertiary prevention.

Detailed Description

After being informed about the study and giving written informed consent, all eligible participants will be randomised into the experimental group or the control group (TAU). Participants will be blind to the group allocation.

The experimental group will undergo a two weeks OCD prevention program, consisting of three group sessions per week.

The control group will not receive any intervention.

Researchers will compare the experimental group to the control group to test wether the prevention programme is efficient in reducing OCD symptomatology.

Study Timeline

• Study First Submitted: 2024-02-08
• Study First Submitted QC: 2024-02-08
• Study Start: 2024-02-09
• Study First Posted: 2024-02-16
• Status Verified: 2025-03
• Last Update Submitted: 2025-04-16
• Last Update Posted: 2025-04-18
• Primary Completion: 2025-07-31
• Study Completion: 2025-12-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• age over 18

Exclusion Criteria

• clinically diagnosed OCD
• current psychiatric/psychotherapeutic treatment
• personality disorder diagnosis
• suicidal ideation

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Prevention	Prevention	6 group, online sessions over two weeks. A prevention program using cognitive and behavioral strategies to reduce OCD risk factors and related symptoms.

Primary Outcome Measures

Name	Time	Method
Change from baseline in depressive symptoms on the PHQ-9 after the intervention	Baseline and Week 2	The PHQ-9 is a validated self-report instrument assessing depressive symptoms. Possible scores range from 0 to 27.; Change = end of intervention score - baseline score
Change from baseline in anxiety symptoms on the GAD-7 after the intervention	Baseline and Week 2	The GAD-7 is a validated self-report instrument assessing anxiety symptoms. Possible scores range from 0 to 21.; Change = end of intervention score - baseline score
Change from baseline in OCD symptoms on the OCI-R after the intervention	Baseline and Week 2	The OCI-R is a validated self-report instrument assessing OCD symptoms. Possible scores range from 0 to 72. Change = end of intervention score - baseline score

Secondary Outcome Measures

Name	Time	Method
Change from baseline in resilience on the RSA after the intervention	Baseline and Week 2	The RSA is a validated self-report instrument assessing resilience in adults. Possible scores range from 43 to 215.; Change = end of intervention score - baseline score
Change from baseline in experiential avoidance on the EAQ after the intervention	Baseline and Week 2	The EAQ is a validated self-report instrument assessing experiential avoidance. Possible scores range from 15 to 90.; Change = end of intervention score - baseline score
Change from baseline in cognitive distortions on the OBQ-44 after the intervention	Baseline and Week 2	The OBQ-44 is a validated self-report instrument assessing cognitive distortions in OCD. Possible scores range from 7 to 308.; Change = end of intervention score - baseline score
Change from baseline in uncertainty intolerance on the IUS after the intervention	Baseline and Week 2	The IUS is a validated self-report instrument assessing intolerance of uncertainty. Possible scores range from 27 to 135.; Change = end of intervention score - baseline score

Trial Locations

Locations (1)

Babes-Bolyai University, Faculty of Psychology and Educational Sciences, Department of Clinical Psychology and Psychotherapy; 🇷🇴 Cluj-Napoca, Romania